Dr. Brumfield’s Remarks at Partnering for Cures Dr. Martha Brumfield, C-Path’s President and CEO, participated in a panel discussion on November 17, 2014, “Playing ni
The Honorable Jim Greenwood discusses the art and science of multi-stakeholder collaborations The Honorable Jim Greenwood, President and CEO of Biotechnology Industry Organization (BIO) and C-Path Board member, participated
Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, on FDA’s Critical Path Initiative